What moved ALNA stock today?

ALNA stock moved on unusually high volume of **252,311,606** shares and intraday volatility between **$0.06** and **$0.1459**, driven by speculative trading and attention to Allena’s clinical pipeline and financing considerations.

What is Meyka AI’s view on ALNA stock?

Meyka AI rates ALNA **62.51/100 (B, HOLD)** and models a 12-month baseline of **$0.12**, implying **60.00%** upside from **$0.075**. These are model projections and not investment guarantees.

What financial risks should investors watch for ALNA stock?

Investors should watch potential equity dilution, negative EPS (**-0.64**), reliance on trial outcomes, and thin liquidity that can widen spreads. Cash per share (**$0.92**) helps near-term runway but may not avoid future financing.

How can traders manage ALNA stock volatility?

Use small position sizes, limit orders, and stop protections. Monitor clinical announcements, sector news, and volume spikes. Expect wide bid-ask spreads and rapid intraday swings in ALNA stock.

US Stocks

ALNA Allena Pharmaceuticals NASDAQ Feb 2026 close $0.075, 252M vol: what’s next

ByDanny Kontos February 25, 2026February 25, 2026

ALNA stock closed at $0.075 on Feb 2026 after 252,311,606 shares traded on the NASDAQ in the United States. The session was marked by high volume and volatile price swings between $0.06 and $0.1459, with the stock ending up 3.16% on the day. Traders focused on Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) because the company’s clinical timetable and cash runway drive near-term moves. Meyka AI provides real-time context and model-based views for active traders